PubRank

Amiram Gafni

Author PubWeight™ 198.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ 2006 5.70
2 A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med 2013 5.06
3 Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015 5.03
4 Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA 2004 4.18
5 Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008 3.41
6 Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition. Med Care 2002 3.05
7 Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med 2007 2.82
8 Requirements for physicians in 2030: why population aging matters less than you may think. CMAJ 2003 2.73
9 Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst 2003 2.51
10 Effectiveness of home visitation by public-health nurses in prevention of the recurrence of child physical abuse and neglect: a randomised controlled trial. Lancet 2005 2.46
11 A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect 2006 2.30
12 Outcomes of children at 2 years after planned cesarean birth versus planned vaginal birth for breech presentation at term: the International Randomized Term Breech Trial. Am J Obstet Gynecol 2004 2.26
13 Treatment decision aids: conceptual issues and future directions. Health Expect 2005 2.25
14 Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol 2009 2.24
15 Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013 2.18
16 Effect on birth outcomes of a formalised approach to care in hospital labour assessment units: international, randomised controlled trial. BMJ 2008 2.11
17 Economists' dream or nightmare? Maximizing health gains from available resources using the NICE guidelines. Health Econ Policy Law 2007 2.06
18 Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. Soc Sci Med 2003 2.01
19 Shared treatment decision making: what does it mean to physicians? J Clin Oncol 2003 1.97
20 Effectiveness of nurses as providers of birth labor support in North American hospitals: a randomized controlled trial. JAMA 2002 1.94
21 Maternal outcomes at 2 years after planned cesarean section versus planned vaginal birth for breech presentation at term: the international randomized Term Breech Trial. Am J Obstet Gynecol 2004 1.83
22 Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 2004 1.80
23 Conceptualizing and validating the human services integration measure. Int J Integr Care 2004 1.75
24 Hospital and home chemotherapy for children with leukemia: a randomized cross-over study. Pediatr Blood Cancer 2006 1.72
25 The risks of waiting for cardiac catheterization: a prospective study. CMAJ 2002 1.70
26 Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach. Health Expect 2004 1.67
27 Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 2002 1.63
28 Sex differences in hospital admissions from emergency departments in asthmatic adults: a population-based study. Ann Allergy Asthma Immunol 2006 1.57
29 Outcomes at 3 months after planned cesarean vs planned vaginal delivery for breech presentation at term: the international randomized Term Breech Trial. JAMA 2002 1.56
30 Exploring the effects of population change on the costs of physician services. J Health Econ 2002 1.55
31 Shared decision making in the medical encounter: are we all talking about the same thing? Med Decis Making 2007 1.53
32 Understanding cardiopulmonary resuscitation decision making: perspectives of seriously ill hospitalized patients and family members. Chest 2006 1.53
33 Shared decision-making in primary care: tailoring the Charles et al. model to fit the context of general practice. Patient Educ Couns 2005 1.46
34 An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 2008 1.44
35 The seriously ill hospitalized patient: preferred role in end-of-life decision making? J Crit Care 2003 1.40
36 Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey. J Obstet Gynaecol Can 2004 1.38
37 A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial. Health Expect 2009 1.34
38 Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 2005 1.31
39 Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation 2003 1.27
40 Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord 2005 1.27
41 The effectiveness and efficiency of home-based nursing health promotion for older people: a review of the literature. Med Care Res Rev 2006 1.27
42 Cultural influences on the physician-patient encounter: The case of shared treatment decision-making. Patient Educ Couns 2006 1.26
43 The 'NICE' approach to technology assessment: an economics perspective. Health Care Manag Sci 2004 1.25
44 Lessons learned from the Decision Board: a unique and evolving decision aid. Health Expect 2000 1.25
45 End-of-life care in acute care hospitals in Canada: a quality finish? J Palliat Care 2005 1.22
46 Discussing prognosis with patients and their families near the end of life: impact on satisfaction with end-of-life care. Open Med 2009 1.17
47 Effective/efficient mental health programs for school-age children: a synthesis of reviews. Soc Sci Med 2004 1.17
48 The Diabetes Continuity of Care Scale: the development and initial evaluation of a questionnaire that measures continuity of care from the patient perspective. Health Soc Care Community 2004 1.16
49 Information created to evade reality (ICER): things we should not look to for answers. Pharmacoeconomics 2006 1.15
50 Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions. Soc Sci Med 2002 1.13
51 The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One 2009 1.11
52 Impact of the international term breech trial on clinical practice and concerns: a survey of centre collaborators. J Obstet Gynaecol Can 2003 1.11
53 Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results. Health Policy 2003 1.09
54 Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis. J Clin Epidemiol 2006 1.09
55 An economic analysis of management strategies for closed and open grade I tibial shaft fractures. Acta Orthop 2005 1.05
56 The costs of planned cesarean versus planned vaginal birth in the Term Breech Trial. CMAJ 2006 1.05
57 Medical practice variations: what the literature tells us (or does not) about what are warranted and unwarranted variations. J Eval Clin Pract 2011 1.05
58 Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid 2007 1.03
59 Editorial: special conference issue. Health Expect 2000 1.01
60 Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results. Med Decis Making 2009 1.01
61 The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study. Eur J Cardiovasc Prev Rehabil 2004 1.00
62 Users and suppliers of physician services: a tale of two populations. Int J Health Serv 2009 1.00
63 The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 2004 1.00
64 The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold. J Health Serv Res Policy 2006 1.00
65 The prevalence, correlates, and costs of depression in people living with HIV/AIDS in Ontario: implications for service directions. AIDS Educ Prev 2005 0.97
66 Health promotion for frail older home care clients. J Adv Nurs 2006 0.97
67 A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf) 2008 0.96
68 Core competencies for shared decision making training programs: insights from an international, interdisciplinary working group. J Contin Educ Health Prof 2013 0.96
69 Correlation of the Canadian Pediatric Emergency Triage and Acuity Scale to ED resource utilization. Am J Emerg Med 2008 0.96
70 A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocr Disord 2004 0.96
71 A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents. PLoS One 2010 0.95
72 Clinician's use of the Statin Choice decision aid in patients with diabetes: a videographic study nested in a randomized trial. J Eval Clin Pract 2009 0.94
73 Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. Am J Cardiol 2007 0.94
74 Interprofessional stroke rehabilitation for stroke survivors using home care. Can J Neurol Sci 2011 0.93
75 Is there an economic rationale for cancer drugs to have a separate reimbursement review process for resource allocation purposes? Pharmacoeconomics 2015 0.93
76 Incorporating patient preferences into orthopaedic practice: should the orthopaedic encounter change? Injury 2006 0.93
77 The effects and costs of a multifactorial and interdisciplinary team approach to falls prevention for older home care clients 'at risk' for falling: a randomized controlled trial. Can J Aging 2010 0.93
78 Development and pretesting of a decision-aid to use when counseling parents facing imminent extreme premature delivery. J Pediatr 2011 0.93
79 A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol (Oxf) 2007 0.92
80 The development and testing of a new communication tool to help clinicians inform patients with obstructive sleep apnoea syndrome about treatment options. J Sleep Res 2012 0.92
81 Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer. J Clin Oncol 2012 0.91
82 A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment. Patient Educ Couns 2010 0.91
83 Women's perceptions of their treatment decision-making about breast cancer treatment. Patient Educ Couns 2008 0.91
84 Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States. Thyroid 2007 0.90
85 Physician-related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients. Health Expect 2011 0.90
86 Family physician attitudes about prescribing using a drug formulary. BMC Fam Pract 2009 0.90
87 What is the number of older Canadians needed to screen by measurement of bone density to detect an undiagnosed case of osteoporosis? a population-based study from CaMos. J Clin Densitom 2006 0.90
88 Nurse-led health promotion interventions improve quality of life in frail older home care clients: lessons learned from three randomized trials in Ontario, Canada. J Eval Clin Pract 2011 0.90
89 Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes. Pediatrics 2010 0.89
90 The evidence-based medicine model of clinical practice: scientific teaching or belief-based preaching? J Eval Clin Pract 2010 0.89
91 The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC). BMC Med Educ 2009 0.89
92 Seeking a second opinion: do patients need a second opinion when practice guidelines exist? Health Policy 2006 0.88
93 Impact of support services provided by a community-based AIDS service organization on persons living with HIV/AIDS. J Assoc Nurses AIDS Care 2006 0.87
94 Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial. Trials 2010 0.87
95 Outcomes and metrics: measuring the impact of a comprehensive adolescent and young adult cancer program. Cancer 2011 0.87
96 The influence of child abuse on the pattern of expenditures in women's adult health service utilization in Ontario, Canada. Soc Sci Med 2006 0.87
97 Hip fracture prevention strategies in long-term care: a survey of Canadian physicians' opinions. Can Fam Physician 2010 0.87
98 Determining optimal population rates of cardiac catheterization: a phantom alternative? CMAJ 2005 0.86
99 Achievements and challenges of medicare in Canada: Are we there yet? Are we on course? Int J Health Serv 2005 0.86
100 Economic evaluation of the MEDENOX trial: a Canadian perspective. Medical Patients with Enoxaparin. Can Respir J 2002 0.86
101 Reflexive planning for later life. Can J Aging 2004 0.86
102 Walking a tightrope: oncologists' perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter. Support Care Cancer 2011 0.85
103 Treatment of displaced femoral neck fractures in the elderly: a cost-benefit analysis. J Orthop Trauma 2009 0.85
104 Are health states 'timeless'? A case study of an acute condition: post-chemotherapy nausea and vomiting. J Eval Clin Pract 2003 0.85
105 Waiting for hip revision surgery: the impact on patient disability. Can J Surg 2008 0.85
106 Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol 2012 0.85
107 Improvement in health-related quality of life in osteoporosis patients treated with teriparatide. BMC Musculoskelet Disord 2008 0.85
108 Capacity planning for cardiac catheterization: a case study. Health Policy 2006 0.84
109 Effect of gender, age, and severity of asthma attack on patterns of emergency department visits due to asthma by month and day of the week. Eur J Epidemiol 2005 0.84
110 Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age? BMC Endocr Disord 2005 0.84
111 The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia. Surg Endosc 2007 0.83
112 Optimizing care in osteoporosis: the Canadian quality circle project. BMC Musculoskelet Disord 2008 0.83
113 Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario. Healthc Policy 2007 0.83
114 The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes. Health Econ 2002 0.83
115 On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales. Health Econ 2002 0.83
116 Cost analysis of monitoring asthma treatment using sputum cell counts. Can Respir J 2008 0.83
117 Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey. J Clin Epidemiol 2005 0.82
118 Developing and pre-testing a decision board to facilitate informed choice about delivery approach in uncomplicated pregnancy. BMC Pregnancy Childbirth 2009 0.82
119 The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation. Thyroid 2013 0.82
120 An even smaller area variation: differing practice patterns among interventional cardiologists within a single high volume tertiary cardiac centre. Health Policy 2010 0.82
121 Quantitative sputum cell counts to monitor bronchitis: a qualitative study of physician and patient perspectives. Can Respir J 2013 0.82
122 Is fetal gender associated with emergency department visits for asthma during pregnancy? J Asthma 2006 0.82
123 Putting your money where your mouth is: willingness to pay for dental gel. Pharmacoeconomics 2002 0.82
124 Children receiving chemotherapy at home: perceptions of children and parents. J Pediatr Oncol Nurs 2006 0.82
125 Patient characteristics associated with nocturnal emergency department visits for asthma. J Asthma 2006 0.82
126 Insight into capacity planning for cardiac catheterization services: policy lessons learned from "Looking in the Mirror" over a decade. Health Policy 2009 0.82
127 Using small-area variations to inform health care service planning: what do we 'need' to know? J Eval Clin Pract 2013 0.81
128 Double discounting of QALYs. Health Econ 2003 0.81
129 Ethics, economics and the regulation and adoption of new medical devices: case studies in pelvic floor surgery. BMC Med Ethics 2010 0.81
130 When guidelines don't guide: the effect of patient context on management decisions based on clinical practice guidelines. Acad Med 2015 0.81
131 Canadian Quality Circle pilot project in osteoporosis: rationale, methods, and feasibility. Can Fam Physician 2007 0.81
132 Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations. Soc Sci Med 2004 0.81
133 Changes in children's behavior and costs for service use associated with parents' response to treatment for dysthymia. J Am Acad Child Adolesc Psychiatry 2006 0.80
134 Burden of dysthymia and comorbid illness in adults in a Canadian primary care setting: high rates of psychiatric illness in the offspring. J Affect Disord 2004 0.80
135 Can I accurately predict the impact of an illness and its treatment on my future subjective well-being? A complex question that does not have a simple answer. Health Expect 2006 0.80
136 The vexing problem of defining the meaning, role and measurement of values in treatment decision-making. J Comp Eff Res 2014 0.79
137 The development of a decision aid to elicit treatment preferences for displaced femoral neck fractures. Indian J Orthop 2012 0.79
138 The use of hip protectors in long-term care facilities: a survey of nursing home staff. J Am Med Dir Assoc 2007 0.79
139 Ethical economics and cost-effectiveness analysis: is it ethical to ignore opportunity costs? Expert Rev Pharmacoecon Outcomes Res 2005 0.79
140 A systematic review of the effect of alendronate on bone mineral density in men. J Clin Densitom 2005 0.79
141 A cross-sectional study of the prevalence, correlates, and costs of falls in older home care clients 'at risk' for falling. Can J Aging 2010 0.79
142 Association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years: multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5). BMC Pregnancy Childbirth 2014 0.79
143 Mothers' views of their childbirth experiences 2 years after planned Caesarean versus planned vaginal birth for breech presentation at term, in the international randomized Term Breech Trial. J Obstet Gynaecol Can 2005 0.79
144 Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey. Endocr Pract 2008 0.78
145 Characteristics of people living with HIV who use community-based services in Ontario, Canada: implications for service providers. J Assoc Nurses AIDS Care 2006 0.78
146 Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis. Chronic Dis Can 2003 0.78
147 Women's perceptions of their involvement in treatment decision making for early stage breast cancer. Support Care Cancer 2013 0.78
148 Can contraindications compromise evidence-based, patient-centered clinical practice? Can J Clin Pharmacol 2006 0.78
149 Family physicians' personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing. Popul Health Manag 2009 0.77
150 Testing the evolution process of prostate-specific antigen in early stage prostate cancer: what is the proper underlying model? Stat Med 2011 0.77
151 Survival rates in extremely low birthweight infants depend on the denominator: avoiding potential for bias by specifying denominators. Am J Obstet Gynecol 2011 0.77
152 Economics of preoperative radiotherapy with total mesorectal excision: what can we learn from the Dutch experience? J Clin Oncol 2003 0.77
153 The statutory duty of physicians to inform patients versus unmet patients' information needs: the case of breast cancer in France. Health Policy 2009 0.77
154 Patients' with obstructive sleep apnoea syndrome (OSAS) preferences and demand for treatment: a discrete choice experiment. Thorax 2012 0.77
155 Evaluating health-related quality of life and priority health problems in patients with prostate cancer: a strategy for defining the role of the advanced practice nurse. Can Oncol Nurs J 2010 0.77
156 Internal validation of models with several interventions. Eur J Health Econ 2012 0.76
157 Maternal side-effects after multiple courses of antenatal corticosteroids (MACS): the three-month follow-up of women in the randomized controlled trial of MACS for preterm birth study. J Obstet Gynaecol Can 2011 0.76
158 Assessing the conceptual clarity and evidence base of quality criteria/standards developed for evaluating decision aids. Health Expect 2011 0.76
159 The NICE reference case requirement: more pain for what, if any, gain? Pharmacoeconomics 2004 0.75
160 The additive utility assumption of the QALY model revisited. J Health Econ 2009 0.75
161 Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshop. J Multidiscip Healthc 2008 0.75
162 Defining patient-based minimal clinically important effect sizes: a study in palliative radiotherapy for painful unresectable pelvic recurrences from rectal cancer. Int J Radiat Oncol Biol Phys 2002 0.75
163 Designing, Implementing, and Evaluating Mobile Health Technologies for Managing Chronic Conditions in Older Adults: A Scoping Review. JMIR Mhealth Uhealth 2016 0.75
164 Building bridges between academic research and policy formulation: when costing less means costing more. Pharmacoeconomics 2007 0.75
165 Is positron emission tomography for the management of potentially operable non-small cell lung cancer an efficient use of Quebec health care resources? Can Respir J 2005 0.75
166 The HAART side of resource allocation. CMAJ 2003 0.75
167 The 2-year costs and effects of a public health nursing case management intervention on mood-disordered single parents on social assistance. J Eval Clin Pract 2002 0.75
168 Oncologists' Perceptions of Recurrent Ovarian Cancer Patients' Preference for Participation in Treatment Decision Making and Strategies for When and How to Involve Patients in This Process. Int J Gynecol Cancer 2015 0.75
169 Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease. J Med Econ 2008 0.75
170 Robotic radiosurgery for the treatment of 1-3 brain metastases: a pragmatic application of cost-benefit analysis using willingness-to-pay. Technol Cancer Res Treat 2013 0.75
171 A stochastic approach to risk management for prostate cancer patients on active surveillance. J Theor Biol 2011 0.75
172 The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trial. Can J Cardiol 2011 0.75
173 Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor. Expert Rev Pharmacoecon Outcomes Res 2013 0.75
174 Home chemotherapy for children with cancer: perspectives from health care professionals. Health Soc Care Community 2004 0.75
175 An intelligent agent approach to improving the coordination efficiency in the donor kidney distribution process. Int J Electron Healthc 2007 0.75
176 The German method for setting ceiling prices for drugs: in some cases less data are required. Expert Rev Pharmacoecon Outcomes Res 2011 0.75
177 Recreation for children on social assistance, 4-17 years old, pays for itself the same year. J Public Health (Oxf) 2006 0.75
178 Estimation, power and sample size calculations for stochastic cost and effectiveness analysis. Pharmacoeconomics 2007 0.75
179 Training costs and investment payback of implementing molecular diagnostics for identification of vancomycin resistant enterococci in a clinical microbiology laboratory. Diagn Microbiol Infect Dis 2002 0.75
180 The Silence in Hoch et al.'s Commentary about the Rationale for and Objective(s) of Canada's Separate HTA Process for Cancer Drugs: The Importance of Transparency and Accountability when Allocating Taxpayers' Dollars. Pharmacoeconomics 2015 0.75
181 The costs and effects of addressing the needs of vulnerable populations: results of 10 years of research. Can J Nurs Res 2009 0.75
182 A primary care cardiovascular risk reduction clinic in Canada was more effective and no more expensive than usual on-demand primary care--a randomised controlled trial. Health Soc Care Community 2009 0.75
183 The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study. J Med Econ 2011 0.75
184 The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study. J Med Econ 2014 0.75